Nuclear Medicine Software Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Nuclear Medicine Software Market 

5.1. COVID-19 Landscape: Nuclear Medicine Software Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Nuclear Medicine Software Market, By Product Type

8.1. Nuclear Medicine Software Market Revenue and Volume, by Product Type

8.1.1. Image Processing & Analysis Software

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Workflow Management Software

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Quantification & Analytics Software

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Radiopharmacy Management Software

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Other Software Solutions

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Nuclear Medicine Software Market, By Modality

9.1. Nuclear Medicine Software Market Revenue and Volume, by Modality

9.1.1. Positron Emission Tomography (PET)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Single Photon Emission Computed Tomography (SPECT)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Planar Scintigraphy

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Nuclear Medicine Software Market, By Deployment Mode 

10.1. Nuclear Medicine Software Market Revenue and Volume, by Deployment Mode

10.1.1. On-Premises

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Cloud-Based / Web-Based

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Hybrid

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Nuclear Medicine Software Market, By Application

11.1. Nuclear Medicine Software Market Revenue and Volume, by Application

11.1.1. Oncology

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Cardiology

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Neurology

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Endocrinology

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Orthopaedics

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Other Clinical Applications

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Nuclear Medicine Software Market, By End User

12.1. Nuclear Medicine Software Market Revenue and Volume, by End User

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Diagnostic Imaging Centers

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Pharmaceutical & Biotechnology Companies

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Radio pharmacies

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Nuclear Medicine Software Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by  Product Type

13.1.2. Market Revenue and Volume Forecast, by Modality

13.1.3. Market Revenue and Volume Forecast, by Deployment Mode

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by  Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Modality

13.1.6.3. Market Revenue and Volume Forecast, by Deployment Mode

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by  Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Modality

13.1.7.3. Market Revenue and Volume Forecast, by Deployment Mode

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by  Product Type

13.2.2. Market Revenue and Volume Forecast, by Modality

13.2.3. Market Revenue and Volume Forecast, by Deployment Mode

13.2.4. Market Revenue and Volume Forecast, by Application  

13.2.5. Market Revenue and Volume Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by  Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Modality

13.2.6.3. Market Revenue and Volume Forecast, by Deployment Mode

13.2.7. Market Revenue and Volume Forecast, by Application  

13.2.8. Market Revenue and Volume Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by  Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Modality

13.2.9.3. Market Revenue and Volume Forecast, by Deployment Mode

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by  Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Modality

13.2.12.3. Market Revenue and Volume Forecast, by Deployment Mode

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by  Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Modality

13.2.14.3. Market Revenue and Volume Forecast, by Deployment Mode

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by  Product Type

13.3.2. Market Revenue and Volume Forecast, by Modality

13.3.3. Market Revenue and Volume Forecast, by Deployment Mode

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by  Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Modality

13.3.6.3. Market Revenue and Volume Forecast, by Deployment Mode

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by  Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Modality

13.3.8.3. Market Revenue and Volume Forecast, by Deployment Mode

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by  Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Modality

13.3.10.3. Market Revenue and Volume Forecast, by Deployment Mode

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by  Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Modality

13.3.11.3. Market Revenue and Volume Forecast, by Deployment Mode

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by  Product Type

13.4.2. Market Revenue and Volume Forecast, by Modality

13.4.3. Market Revenue and Volume Forecast, by Deployment Mode

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by  Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Modality

13.4.6.3. Market Revenue and Volume Forecast, by Deployment Mode

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by  Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Modality

13.4.8.3. Market Revenue and Volume Forecast, by Deployment Mode

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by  Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Modality

13.4.10.3. Market Revenue and Volume Forecast, by Deployment Mode

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by  Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Modality

13.4.11.3. Market Revenue and Volume Forecast, by Deployment Mode

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by  Product Type

13.5.2. Market Revenue and Volume Forecast, by Modality

13.5.3. Market Revenue and Volume Forecast, by Deployment Mode

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by  Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Modality

13.5.6.3. Market Revenue and Volume Forecast, by Deployment Mode

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by  Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Modality

13.5.8.3. Market Revenue and Volume Forecast, by Deployment Mode

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. GE?HealthCare

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Hermes?Medical?Solutions

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens?Healthineers

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bracco?Group

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Lantheus?Holdings

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Koninklijke?Philips?N.V

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. COMECER?S.p.A.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Mirada?Medical

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. LabLogic?Systems

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DOSIsoft?SA

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms